Black Diamond Therapeutics, Inc. Profile Avatar - Palmy Investing

Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic …

Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of BDTX's Analysis
CIK: 1701541 CUSIP: 09203E105 ISIN: US09203E1055 LEI: - UEI: -
Secondary Listings
BDTX has no secondary listings inside our databases.